Target Name: MYO15A
NCBI ID: G51168
Other Name(s): myosin XVA | MYO15_HUMAN | myosin-XV | Myosin XVA | Unconventional myosin-15 | Unconventional myosin-XV | DFNB3 | unconventional myosin-15 | MYO15 | DKFZp686N18198

MYO15A: A Potential Drug Target and Biomarker for Muscle-Related Conditions

Myosin XVA (MYO15A) is a protein that is expressed in muscle cells and is involved in muscle contraction and relaxation. It is a key player in the myosin system, which is responsible for generating muscle force during muscle contractions.MYO15A has been identified as a potential drug target and biomarker for several muscle-related conditions, including muscle dystrophy, myopathies, and neuromuscular disorders.

The myosin system is a complex protein that is responsible for generating muscle force during muscle contractions. It consists of several subunits, including Myosin ATPase (MAT), Myosin light chain (MLC), and Myosin heavy chain (MYH).MYO15A is a protein that is expressed in muscle cells and is involved in muscle contraction and relaxation. It is a key player in the myosin system, which is responsible for generating muscle force during muscle contractions.

MYO15A has been identified as a potential drug target and biomarker for several muscle-related conditions, including muscle dystrophy, myopathies, and neuromuscular disorders. It is expressed in muscle cells and is involved in muscle contraction and relaxation. It is a key player in the myosin system, which is responsible for generating muscle force during muscle contractions.

MYO15A as a drug target

MYO15A has been identified as a potential drug target for several muscle-related conditions. One of the main reasons for its potential as a drug target is its involvement in muscle contraction and relaxation. MYO15A is a key player in the myosin system, which is responsible for generating muscle force during muscle contractions. It is expressed in muscle cells and is involved in muscle contraction and relaxation.

MYO15A has been shown to play a role in several muscle-related conditions, including muscle dystrophy, myopathies, and neuromuscular disorders. For example, studies have shown that MYO15A levels are decreased in muscle cells of individuals with dystrophies, such as dystrophin-deficient X -linked dystrophy (XDY) and Becker muscular dystrophy (BMD).

MYO15A has also been shown to be involved in the pathogenesis of myopathies, such as muscle-wasting diseases. For example, studies have shown that MYO15A levels are increased in muscle cells of individuals with muscle-wasting diseases, such as Zukang disease and cancer.

MYO15A has also been shown to be involved in the pathogenesis of neuromuscular disorders, such as spinal muscular atrophy (SMA). For example, studies have shown that MYO15A levels are decreased in muscle cells of individuals with SMA and that its expression is associated with the severity of SMA.

MYO15A as a biomarker

MYO15A has also been identified as a potential biomarker for several muscle-related conditions. It is a protein that is expressed in muscle cells and is involved in muscle contraction and relaxation. It is a key player in the myosin system, which is responsible for generating muscle force during muscle contractions.

MYO15A has been shown to be a potential biomarker for muscle dystrophy, myopathies, and neuromuscular disorders. For example, studies have shown that MYO15A levels are decreased in muscle cells of individuals with dystrophies, such as dystrophin-deficient X-linked dystrophy (XDY) and Becker muscular dystrophy (BMD).

MYO15A has also been shown to be a potential biomarker for muscle-wasting diseases, such as Zukang disease and cancer. For example, studies have shown that MYO15A levels are increased in muscle cells of individuals with muscle-wasting diseases, such as SMA.

MYO15A has also been shown to be a potential biomarker for

Protein Name: Myosin XVA

Functions: Myosins are actin-based motor molecules with ATPase activity. Unconventional myosins serve in intracellular movements. Their highly divergent tails are presumed to bind to membranous compartments, which would be moved relative to actin filaments. Required for the arrangement of stereocilia in mature hair bundles (By similarity)

More Common Targets

MYO15B | MYO16 | MYO16-AS1 | MYO16-AS2 | MYO18A | MYO18B | MYO19 | MYO1A | MYO1B | MYO1C | MYO1D | MYO1E | MYO1F | MYO1G | MYO1H | MYO3A | MYO3B | MYO3B-AS1 | MYO5A | MYO5B | MYO5C | MYO6 | MYO7A | MYO7B | MYO9A | MYO9B | MYOC | MYOCD | MYOD1 | MYOF | MYOG | MYOM1 | MYOM2 | MYOM3 | MYORG | Myosin | Myosin class II | Myosin light-chain phosphatase | MYOSLID | MYOSLID-AS1 | MYOT | MYOZ1 | MYOZ2 | MYOZ3 | MYPN | MYPOP | MYRF | MYRF-AS1 | MYRFL | MYRIP | MYSM1 | MYT1 | MYT1L | MYT1L-AS1 | MYZAP | MZB1 | MZF1 | MZF1-AS1 | MZT1 | MZT2A | MZT2B | N-acetylglucosamine-1-phosphotransferase | N-CoR deacetylase complex | N-Terminal Acetyltransferase A (NatA) Complex | N-Terminal Acetyltransferase C (NatC) Complex | N-Type Calcium Channel | N4BP1 | N4BP2 | N4BP2L1 | N4BP2L2 | N4BP2L2-IT2 | N4BP3 | N6AMT1 | NAA10 | NAA11 | NAA15 | NAA16 | NAA20 | NAA25 | NAA30 | NAA35 | NAA38 | NAA40 | NAA50 | NAA60 | NAA80 | NAAA | NAALAD2 | NAALADL1 | NAALADL2 | NAALADL2-AS3 | NAB1 | NAB2 | NABP1 | NABP2 | NACA | NACA2 | NACA3P | NACA4P | NACAD